Maki RG - Search Results

1

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

D'Adamo DR, Dickson MA, Keohan ML, Carvajal RD, Hensley ML, Hirst CM, Ezeoke MO, Ahn L, Qin LX, Antonescu CR, Lefkowitz RA, Maki RG, Schwartz GK, Tap WD. D'Adamo DR, et al. Among authors: maki rg. Oncologist. 2019 Jun;24(6):857-863. doi: 10.1634/theoncologist.2018-0160. Epub 2018 Aug 20. Oncologist. 2019. PMID: 30126857 Free PMC article. Clinical Trial.

2

Sarcoma.

Maki R. Maki R. Oncologist. 2001;6(4):333-7. doi: 10.1634/theoncologist.6-4-333. Oncologist. 2001. PMID: 11524551 Free article. Review.

3

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R, Spriggs DR. Hensley ML, et al. J Clin Oncol. 2002 Jun 15;20(12):2824-31. doi: 10.1200/JCO.2002.11.050. J Clin Oncol. 2002. PMID: 12065559 Clinical Trial.

4

Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.

Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. Maki RG, et al. Int J Cancer. 2002 Aug 20;100(6):623-6. doi: 10.1002/ijc.10535. Int J Cancer. 2002. PMID: 12209598

5

A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors.

Ryan DP, Puchalski T, Supko JG, Harmon D, Maki R, Garcia-Carbonero R, Kuhlman C, Winkelman J, Merriam P, Quigley T, Jimeno J, Manola J, Demetri GD. Ryan DP, et al. Oncologist. 2002;7(6):531-8. doi: 10.1634/theoncologist.7-6-531. Oncologist. 2002. PMID: 12490740 Free article. Clinical Trial.

6

Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor.

Dematteo RP, Maki RG, Antonescu C, Brennan MF. Dematteo RP, et al. Among authors: maki rg. Curr Probl Surg. 2003 Mar;40(3):144-93. doi: 10.1067/msg.2003.022223. Curr Probl Surg. 2003. PMID: 12571542 Review. No abstract available.

7

Classification and subtype prediction of adult soft tissue sarcoma by functional genomics.

Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, Woodruff JM, Lewis JJ, Brennan MF, Houghton AN, Cordon-Cardo C. Segal NH, et al. Among authors: maki rg. Am J Pathol. 2003 Aug;163(2):691-700. doi: 10.1016/S0002-9440(10)63696-6. Am J Pathol. 2003. PMID: 12875988 Free PMC article.

8

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.

Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P. Antonescu CR, et al. Clin Cancer Res. 2003 Aug 15;9(9):3329-37. Clin Cancer Res. 2003. PMID: 12960119

9

Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia.

Robson ME, Glogowski E, Sommer G, Antonescu CR, Nafa K, Maki RG, Ellis N, Besmer P, Brennan M, Offit K. Robson ME, et al. Among authors: maki rg. Clin Cancer Res. 2004 Feb 15;10(4):1250-4. doi: 10.1158/1078-0432.ccr-03-0110. Clin Cancer Res. 2004. PMID: 14977822

10

Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.

Antonescu CR, Viale A, Sarran L, Tschernyavsky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP, Besmer P. Antonescu CR, et al. Among authors: maki rg. Clin Cancer Res. 2004 May 15;10(10):3282-90. doi: 10.1158/1078-0432.CCR-03-0715. Clin Cancer Res. 2004. PMID: 15161681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters